Improved Outcomes Associated With Inositol Dietary Supplementation in Women With Gestational Diabetes Mellitus
NCT ID: NCT01342874
Last Updated: 2012-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2010-08-31
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myo-inositol, D-chiro-inositol, and D-chiro/Myo-inositol in Gestational Diabetes
NCT01762826
Myo-inositol Administration in Gestational Diabetes
NCT00734448
Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus
NCT03875755
Glycemic Impact of Myo-inositol in Pregnancy
NCT02149992
Effect of a Continuous Glucose Monitoring on Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus
NCT02838147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inositol group
Inositol dietary exposure 4000 mg/day
Inositol
inositol exposure in early GDM
Control group
folic acid 400 mcg/day
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inositol
inositol exposure in early GDM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* random fasting glucose above 92 mg%
Exclusion Criteria
* random fasting glucose above 126 mg%
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
G. d'Annunzio University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudio Celentano
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudio Celentano, MD
Role: PRINCIPAL_INVESTIGATOR
ObGyn Dept
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Chieti
Chieti, CH, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Corrado F, D'Anna R, Di Vieste G, Giordano D, Pintaudi B, Santamaria A, Di Benedetto A. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011 Aug;28(8):972-5. doi: 10.1111/j.1464-5491.2011.03284.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INOS001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.